These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 21884865
1. Prognostic value of renin and prorenin in heart failure patients with decreased kidney function. Szymanski MK, Damman K, van Veldhuisen DJ, van Gilst WH, Hillege HL, de Boer RA. Am Heart J; 2011 Sep; 162(3):487-93. PubMed ID: 21884865 [Abstract] [Full Text] [Related]
2. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure. Damman K, van der Harst P, Smilde TD, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL. Heart; 2012 Feb; 98(4):319-24. PubMed ID: 22038544 [Abstract] [Full Text] [Related]
3. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Am J Cardiol; 2010 Apr 15; 105(8):1140-6. PubMed ID: 20381667 [Abstract] [Full Text] [Related]
4. Renal function largely influences Galectin-3 prognostic value in heart failure. Zamora E, Lupón J, de Antonio M, Galán A, Domingo M, Urrutia A, Troya M, Bayes-Genis A. Int J Cardiol; 2014 Nov 15; 177(1):171-7. PubMed ID: 25499371 [Abstract] [Full Text] [Related]
7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651 [Abstract] [Full Text] [Related]
9. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Circulation; 1993 Jun 20; 87(6 Suppl):VI40-8. PubMed ID: 8500238 [Abstract] [Full Text] [Related]
16. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Maeder MT, Rickli H, Pfisterer ME, Muzzarelli S, Ammann P, Fehr T, Hack D, Weilenmann D, Dieterle T, Kiencke S, Estlinbaum W, Brunner-La Rocca HP, TIME-CHF Investigators. Am Heart J; 2012 Mar 21; 163(3):407-14, 414.e1. PubMed ID: 22424011 [Abstract] [Full Text] [Related]
17. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA. Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046 [Abstract] [Full Text] [Related]
18. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Kos T, Pacher R, Wimmer A, Bojic A, Hülsmann M, Frey B, Mayer G, Yilmaz N, Skvarilova L, Spinar J, Vitovec J, Toman J, Woloszcuk W, Stanek B. Wien Klin Wochenschr; 1998 Feb 13; 110(3):89-95. PubMed ID: 9553203 [Abstract] [Full Text] [Related]
19. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data. Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, McMurray JJ, Damman K. Circ Heart Fail; 2017 Feb 13; 10(2):. PubMed ID: 28209765 [Abstract] [Full Text] [Related]